165 related articles for article (PubMed ID: 24395349)
1. Does the existence of HCMV components predict poor prognosis in glioma?
Ding D; Han S; Wang Z; Guo Z; Wu A
J Neurooncol; 2014 Feb; 116(3):515-22. PubMed ID: 24395349
[TBL] [Abstract][Full Text] [Related]
2. Is the presence of HCMV components in CNS tumors a glioma-specific phenomenon?
Ding D; Zhao A; Sun Z; Zuo L; Wu A; Sun J
Virol J; 2019 Aug; 16(1):96. PubMed ID: 31370833
[TBL] [Abstract][Full Text] [Related]
3. [Temporal expression of HCMV IE1 and pp65 in human glioma U(251) cells].
Li JH; Fu Y; Chen LY; Dai G; Luo MH; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):551-6. PubMed ID: 17767040
[TBL] [Abstract][Full Text] [Related]
4. Detection of human cytomegalovirus in different histological types of gliomas.
Scheurer ME; Bondy ML; Aldape KD; Albrecht T; El-Zein R
Acta Neuropathol; 2008 Jul; 116(1):79-86. PubMed ID: 18351367
[TBL] [Abstract][Full Text] [Related]
5. Decreased human leukocyte antigen A*02:01 frequency is associated with risk of glioma and existence of human cytomegalovirus: a case-control study in Northern China.
Han S; Deng J; Wang Z; Liu H; Cheng W; Wu A
Cancer Immunol Immunother; 2017 Oct; 66(10):1265-1273. PubMed ID: 28523518
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression.
Xing Y; Wang Y; Wang S; Wang X; Fan D; Zhou D; An J
Transl Res; 2016 Nov; 177():113-126. PubMed ID: 27474433
[TBL] [Abstract][Full Text] [Related]
7. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma.
Farias KPRA; Moreli ML; Floriano VG; da Costa VG
Arch Virol; 2019 May; 164(5):1249-1257. PubMed ID: 30888562
[TBL] [Abstract][Full Text] [Related]
8. Human cytomegalovirus infection and expression in human malignant glioma.
Cobbs CS; Harkins L; Samanta M; Gillespie GY; Bharara S; King PH; Nabors LB; Cobbs CG; Britt WJ
Cancer Res; 2002 Jun; 62(12):3347-50. PubMed ID: 12067971
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of herpesviruses with brain tumors.
Poltermann S; Schlehofer B; Steindorf K; Schnitzler P; Geletneky K; Schlehofer JR
J Neurovirol; 2006 Apr; 12(2):90-9. PubMed ID: 16798670
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.
Baumgarten P; Michaelis M; Rothweiler F; Starzetz T; Rabenau HF; Berger A; Jennewein L; Braczynski AK; Franz K; Seifert V; Steinbach JP; Allwinn R; Mittelbronn M; Cinatl J
Neuro Oncol; 2014 Nov; 16(11):1469-77. PubMed ID: 25155358
[TBL] [Abstract][Full Text] [Related]
11. Human cytomegalovirus viral load in tumor and peripheral blood samples of patients with malignant gliomas.
Priel E; Wohl A; Teperberg M; Nass D; Cohen ZR
J Clin Neurosci; 2015 Feb; 22(2):326-30. PubMed ID: 25443081
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship.
Melnick M; Sedghizadeh PP; Allen CM; Jaskoll T
Exp Mol Pathol; 2012 Feb; 92(1):118-25. PubMed ID: 22101257
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Human Cytomegalovirus and Human Papillomavirus in Glioma.
Limam S; Missaoui N; Hmissa S; Yacoubi MT; Krifa H; Mokni M; Selmi B
Cancer Invest; 2020 Aug; 38(7):394-405. PubMed ID: 32643440
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5.
Hu M; Wang B; Qian D; Wang M; Huang R; Wei L; Li L; Zhang L; Liu DX
Oncotarget; 2017 May; 8(19):32157-32170. PubMed ID: 28473657
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
16. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity.
Cobbs CS; Soroceanu L; Denham S; Zhang W; Kraus MH
Cancer Res; 2008 Feb; 68(3):724-30. PubMed ID: 18245472
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane-4-L-six-family-1, a potential predictor for poor prognosis, overexpressed in human glioma.
Wang P; Bao W; Zhang G; Cui H; Shi G
Neuroreport; 2015 May; 26(8):455-61. PubMed ID: 25855954
[TBL] [Abstract][Full Text] [Related]
18. Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis.
Amirian ES; Marquez-Do D; Bondy ML; Scheurer ME
Cancer Med; 2013 Feb; 2(1):57-62. PubMed ID: 24133628
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of human cytomegalovirus DNA in gliomas of Brazilian patients.
Fonseca RF; Kawamura MT; Oliveira JA; Teixeira A; Alves G; Carvalho Mda G
Mem Inst Oswaldo Cruz; 2012 Nov; 107(7):953-4. PubMed ID: 23147156
[TBL] [Abstract][Full Text] [Related]
20. Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades.
Stangherlin LM; Castro FL; Medeiros RS; Guerra JM; Kimura LM; Shirata NK; Nonogaki S; Dos Santos CJ; Carlan Silva MC
PLoS One; 2016; 11(7):e0159604. PubMed ID: 27458810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
